Surveyor Health
  • Home
  • JMCP Study
  • SurveyorAI
  • About Us
  • Our Team
  • Contact Us
  • Home
  • JMCP Study
  • SurveyorAI
  • About Us
  • Our Team
  • Contact Us

Studies 

Read the JMCP Study
Economic and Utilization Outcomes of Medication Management at a Large Medicaid Plan with Disease Management Pharmacists using a Novel Artificial Intelligence Platform from 2018 to 2019
Published by The Journal of Managed Care & Specialty Pharmacy (JMCP)
Study results show a 19.3% reduction in the Total Cost of Care
and validates SurveyorAI’s ability to enhance telephonic medication management
while reducing medication risks, lowering costs
​and reducing 
hospital admissions by 9% and emergency room visits by 15%
Picture
Total Cost of Care = Medication Costs plus all non-capitated Medical Costs
​including Inpatient, ER, Physician, Outpatient, Laboratory and Radiology, Community and Home care, Transportation, LTC, and Hospice.
​Based on actual claims, not estimates.

Stanford University guided JMCP Study Demonstrates Savings Opportunity

Clinical Team

3 PharmDs, 2 MAs

Targeting

2,150 high risk patients targeted from 1.25M population
Each patient on an average of 25 medications

SurveyorAI Augmented Interventions

7,485 patient encounters over 14 months with 46,090 regimen changes

$4.5M annual savings

For every 1,000 high risk patients targeted and encountered

$554 saved per member per month

A 19.3% reduction in the Total Cost of Care

Intervention time cut in half

From 60 to 30 minutes
Surveyor Health Demonstrates 19.3% Reduction in Cost of Care
May 2021
Economic and Utilization Outcomes of Medication Management at a Large Medicaid Plan with Disease Management Pharmacists using a Novel Artificial Intelligence Platform from 2018 to 2019
​
Peer reviewed and published by The Journal of Managed Care & Specialty Pharmacy (JMCP)
Picture
Press Release - JMCP Study - Highlights
May 2021
​Peer reviewed study shows 19.3% reduction in cost of care and validates the ability of remote Population Medication Management to lower costs, reduce hospitalization and ER visits

The key findings published in the Journal of Managed Care & Specialty Pharmacy include:

  • Regimen Risk Reduction Stats
    • 15.2% reduction in serious drug-drug interactions
    • 13.1% reduction in duplications of therapy
    • 3.9% reduction in additive adverse events
 
  • Healthcare Savings Stats
    • The economic study found a 19.3% reduction in the total cost of care (TCoC) that yielded a savings of $554 Per Member Per Month. This translates to approximately $1.2M a month and over $14M annually for the 2,150 members in the study.   
    • Medication costs alone showed a 17.4% reduction, which yielded a savings of $192 Per Member Per Month.  
    • The utilization study found a 15% reduction in ER visits, a 9% reduction in Hospital Admits, and a 10% reduction in Bed Days. 
    • Return on Investment is 12.4:1 based on TCoC savings and program costs.
    • Extended to members with similar risks, these interventions will save the Plan at least $109M annually and could save California’s Medi-Cal (Medicaid) nearly $1.2B. This demonstrates how valuable it would be for Medicaid to support this quality of intervention for its members.
 
  • The SurveyorAI platform: 
    • Evaluates a multi-drug regimen as a complex system of varying components, assessing the risks posed by numerous medications often being taken at the same time.
    • Simulates prospective changes to a drug regimen to aid the clinician in deciding the optimal configuration in the face of so many tradeoffs. 
    • Expands the clinician’s knowledge, giving them the ability to, at-a-glance, understand and gain insight into the complexities of the large drug regimens all too common in high risk patients. This improves teamwide clinical consistency. 
    • Reduces overall medication regimen risks, leading to a reduction in healthcare costs. Reducing medication risks improves health and minimizes utilization of services which reduces costs.

Press about our JMCP study


Artificial Intelligence In Pharmacy
​Erick Von Schweber and Ed Jai, PharmD 

Erick Von Schweber, the CEO of Surveyor Health Corporation, in conjunction with Dr. Ed Jai of Inland Empire Health Plan, share insight about medication management, artificial intelligence, and deprescribing.
Picture
The Business of Pharmacy with Mike Koelzer
​October 12, 2021

Listen to the Podcast

IEHP Pilot Program Published in Journal of Managed Care and Specialty Pharmacy
IEHP Latest News and Publications
​September 21, 2021

"In partnership with Surveyor Health, Inland Empire Health Plan’s Pharmacy Comprehensive Medication Management (CMM) Pilot Program, utilizing artificial intelligence (AI) to manage medication use among Members was recently published in the Journal of Managed Care & Specialty Pharmacy." 

"Noting the pilot program’s ability to significantly improve Member health outcomes and reduce utilization, the Journal of Managed Care & Specialty Pharmacy estimates that California’s Medicaid (Medi-Cal) program could save more than $1B annually by applying the program’s measures to a similar group of patients. “This study affirms that Medication Therapy Management for Medicaid patients is essential for optimizing patient care,” said Dr. Michael Blatt, IEHP Clinical Director of Pharmacy and Product Strategy."
Read the IEHP Press Release

Artificial Intelligence Can Improve Outcomes and Reduce the Cost of Care Among Higher Risk Patients
Erick Von Schweber and Joan Kapusnik-Uner, PharmD, FCSHP, FASHP
​August 20, 2021
​Population Health Learning Network: First Report Managed Care
Picture
Picture
Read the Article
"FDB's collaboration with Surveyor Health combines the power of our well-curated and vetted drug data and Surveyor’s AI-based technology to help keep patients safer and healthier" said Bob Katter, president of FDB. 
More about FDB
Picture

Picture
Artificial Intelligence Drives a New Medication Management Philosophy 
HISTalk - By Erick Von Schweber - ​July 12, 2021

There are times when advances in technology enable a radical re-envisioning of both what we do and how we do it. Medication management is at that stage, thanks to ongoing developments in artificial intelligence....
Read the Article

Second Opinion:
​Medicare and Medicaid Medication Misadventures 

Medical World News and Drug Topics
Picture
Interview with Erick and Dr. Ed Jai, our partner at Inland Empire Health Care.
​June 25, 2021

Watch the Interview

New SurveyorAI Platform Applies
​FDB Drug Data to Lower Cost of Care 19.3% in Medicaid Population

FDB (First Databank) Press Release
June 1, 2021
Picture
Read FDB's Press Release

Copyright © 2024  Surveyor Health ​Corporation. All Rights Reserved.

                www.surveyorhealth.com                 [email protected]